{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T03:02:26Z","timestamp":1783652546857,"version":"3.55.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T00:00:00Z","timestamp":1694044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T00:00:00Z","timestamp":1694044800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Freiburg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Low-risk early breast cancer rarely leads to the development of metastatic disease, and in these patients, additional imaging test is controversial. The aim of our study was to evaluate the conventional staging procedures in a bicentric German series of low-risk breast carcinoma patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Retrospective evaluation of all patients diagnosed with early, low-risk breast cancer at Saarland University Hospital and Freiburg University Hospital in 2017 was performed. Clinical patient characteristics, the number and type of additional imaging examinations, follow-up examinations, and results were evaluated. The detection rate of metastases and the rate of false-positive findings were analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 203 patients were included, with all patients received at least one additional imaging test. Initially, a total of 562 additional imaging examinations were performed: 166 chest X-rays, 169 upper abdominal ultrasounds, 199 bone scans, 27 computer tomographies (CT) chest and abdomen, and 1 CT abdomen. 6.8% of patients had abnormal findings reported, requiring 38 additional imaging examinations. One patient (0.5%) was found to have bone metastases. The rate of false-positive findings in the performed additional imaging procedures was 6.6%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Metastatic disease was detected in one of 203 patients with low-risk early breast cancer. A total of 562 examinations and additional 38 follow-up examinations were performed without detection of metastasis (this corresponds to approximately 3 examinations\/patient). The rate of false-positive findings was 6.6%. The performance of additional imaging procedures for detection of distant metastases should be critically reconsidered in patients with low-risk early breast cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00404-023-07169-4","type":"journal-article","created":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T05:02:06Z","timestamp":1694062926000},"page":"1475-1481","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Diagnostic performance of additional imaging tests for staging purposes in a bicentric German series of low-risk early breast cancer patients"],"prefix":"10.1007","volume":"309","author":[{"given":"Lisa","family":"Jung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah Isabelle","family":"Huwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florin-Andrei","family":"Taran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Unger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erich-Franz","family":"Solomayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2178-6490","authenticated-orcid":false,"given":"Ingolf","family":"Juhasz-B\u00f6ss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Neubauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,7]]},"reference":[{"key":"7169_CR1","unstructured":"World Health Organization (WHO), Current and future burden of breast cancer:global statistics for 2020 and 2040. https:\/\/www.iarc.who.int\/news-events\/current-and-future-burden-of-breast-cancer-global-statistics-for-2020-and-2040\/#:~:text=Breast%20cancer%20is%20the%20most,in%208%20cancer%20diagnoses%20worldwide. Assessed June 28, 2023."},{"key":"7169_CR2","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-018-6486-6","author":"Giuliano","year":"2018","unstructured":"Giuliano et al (2018) Eighth Edition of the AJCC cancer staging manual: breast cancer. Ann Surg Oncol. https:\/\/doi.org\/10.1245\/s10434-018-6486-6","journal-title":"Ann Surg Oncol"},{"key":"7169_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6605323","author":"Barrett","year":"2009","unstructured":"Barrett et al (2009) Radiological staging in breast cancer: which asymptomatic patients to image and how. Br J Cancer. https:\/\/doi.org\/10.1038\/sj.bjc.6605323","journal-title":"Br J Cancer"},{"key":"7169_CR4","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S176763)","author":"W Xiao","year":"2018","unstructured":"Xiao W et al (2018) Breast cancer subtypes and the risk of distant metastasis at initial diagnosis: a population-based study. Cancer Manage Res. https:\/\/doi.org\/10.2147\/CMAR.S176763)","journal-title":"Cancer Manage Res"},{"key":"7169_CR5","doi-asserted-by":"publisher","DOI":"10.1677\/ERC-09-0033","author":"F Montemurro","year":"2009","unstructured":"Montemurro F et al (2009) Hormone receptor-positive early breast cancer: controversies in the use of adjuvant chemotherapy. Endocr Relat Cancer. https:\/\/doi.org\/10.1677\/ERC-09-0033","journal-title":"Endocr Relat Cancer"},{"key":"7169_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-015-0514-2","author":"B Gy\u00f6rffy","year":"2015","unstructured":"Gy\u00f6rffy B (2015) Multigene prognostic tests in breast cancer: past, present, future. Breast Cancer. https:\/\/doi.org\/10.1186\/s13058-015-0514-2","journal-title":"Breast Cancer"},{"key":"7169_CR7","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.00945","author":"F Andre","year":"2019","unstructured":"Andre F et al (2019) Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: ASCO Clinical Practice Guideline Update-Integration of Results From TAILORx. J Clin Oncol. https:\/\/doi.org\/10.1200\/JCO.19.00945","journal-title":"J Clin Oncol"},{"key":"7169_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.923371","author":"H Sun","year":"2022","unstructured":"Sun H et al (2022) Comparisons of metastatic patterns, survival outcomes and tumor immune microenvironment between young and non-young breast cancer patients. Front Cell Dev Boil. https:\/\/doi.org\/10.3389\/fcell.2022.923371","journal-title":"Front Cell Dev Boil"},{"issue":"10","key":"7169_CR9","first-page":"1439","volume":"164","author":"RE Myers","year":"2001","unstructured":"Myers RE, Johnston M, Pritchard K, Levine M, Oliver T (2001) Breast Cancer disease site group of the cancer care ontario practice guidelines initiative. Baseline staging tests in primary breast cancer: a practice guideline. CMAJ 164(10):1439\u20131444","journal-title":"CMAJ"},{"issue":"1","key":"7169_CR10","first-page":"1","volume":"3","author":"RO Dillman","year":"2000","unstructured":"Dillman RO, Chico S (2000) Radiologic tests after a new diagnosis of breast cancer. Eff Clin Pract 3(1):1\u20136","journal-title":"Eff Clin Pract"},{"issue":"6","key":"7169_CR11","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.breast.2012.08.001","volume":"21","author":"J James","year":"2012","unstructured":"James J, McMahon MA, Tennan SL, Cornford EJ (2012) CT staging for breast cancer patients with poor prognostic tumours Author links open overlay panel. Breast 21(6):735\u2013738","journal-title":"Breast"},{"issue":"1","key":"7169_CR12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00404-002-0445-x","volume":"269","author":"C Schneider","year":"2003","unstructured":"Schneider C, Fehr MK, Steiner RA, Hagen D, Haller U, Fink D (2003) Frequency and distribution pattern of distant metastases in breast cancer patients at the time of primary presentation. Arch Gynecol Obstet 269(1):9\u201312. https:\/\/doi.org\/10.1007\/s00404-002-0445-x","journal-title":"Arch Gynecol Obstet"},{"key":"7169_CR13","doi-asserted-by":"publisher","first-page":"506172","DOI":"10.1155\/2013\/506172","volume":"2013","author":"N Chand","year":"2013","unstructured":"Chand N, Cutress RI, Oeppen RS, Agrawal A (2013) Staging investigations in breast cancer: collective opinion of UK breast surgeons. Int J Breast Cancer. 2013:506172. https:\/\/doi.org\/10.1155\/2013\/506172","journal-title":"Int J Breast Cancer."},{"issue":"5","key":"7169_CR14","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1001\/archsurg.134.5.551","volume":"134","author":"R Samant","year":"1999","unstructured":"Samant R, Ganguly P (1999) Staging investigations in patients with breast cancer: the role of bone scans and liver imaging. Arch Surg 134(5):551\u2013554","journal-title":"Arch Surg"},{"issue":"1","key":"7169_CR15","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1023\/A:1014900600815","volume":"72","author":"A Ravaioli","year":"2002","unstructured":"Ravaioli A, Pasini G, Polselli A, Papi M et al (2002) Staging of Breast Cancer\u202f:new recommended standard procedure. Breast Cancer Res Treat 72(1):53\u201360","journal-title":"Breast Cancer Res Treat"},{"key":"7169_CR16","unstructured":"Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF): S3-Leitlinie Fr\u00fcherkennung, Diagnose, Therapie und Nachsorge des Mammakarzinoms, Version 4.4, 2021, AWMF Registernummer: 032-045OL, http:\/\/www.leitlinienprogramm-onkologie.de\/leitlinien\/mammakarzinom\/(abgerufenam:01.07.2021)"},{"key":"7169_CR17","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1186\/s40064-016-2703-6","volume":"5","author":"P Rusch","year":"2016","unstructured":"Rusch P, Hoffmann O, Stickelmann A-L, B\u00f6hmer S, G\u00e4tje R, Kr\u00fcger KG, Niesert S, Schmidt A, Kimming R (2016) Distant metastasis detected by routine staging in breast cancer patients participating in the national German screening programme: consequences for clinical practice. Springer Plus 5:1010","journal-title":"Springer Plus"},{"key":"7169_CR18","unstructured":"AGO e. V. in der DGGG e.V. sowie in der DKG e.V. Guidelines Breast Version 2021.1D; Fr\u00fcherkennung und Diagnostik"},{"issue":"9406","key":"7169_CR19","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S0140-6736(04)15433-0","volume":"363","author":"A Berrington de Gonzalez","year":"2004","unstructured":"Berrington de Gonzalez A, Darby S (2004) Risk of cancer from diagnostic X-rays: estimates fort he UKan 14 other countries (2004). Lancet 363(9406):345\u2013351","journal-title":"Lancet"},{"issue":"2","key":"7169_CR20","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1055\/s-0032-1328075","volume":"73","author":"N Eismann","year":"2013","unstructured":"Eismann N, Waldmann A, Katalinic A (2013) Epidemiology of breast cancer current figures and trends. Geburtshilfe Frauenheilkunde 73(2):130\u2013135","journal-title":"Geburtshilfe Frauenheilkunde"},{"issue":"2","key":"7169_CR21","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1159\/000502223","volume":"15","author":"C M\u00fcller","year":"2020","unstructured":"M\u00fcller C, Juhasz-B\u00f6ss S, Schmidt G, Solomayer EF, Juhasz-B\u00f6ss I, Breitbach GP (2020) Factors influencing the onset of neoadjuvant therapy in breast cancer patients. Breast Care (Basel) 15(2):182\u2013187","journal-title":"Breast Care (Basel)"},{"issue":"11","key":"7169_CR22","doi-asserted-by":"publisher","first-page":"8714","DOI":"10.1007\/s00330-021-07956-0","volume":"31","author":"NM Bruckmann","year":"2021","unstructured":"Bruckmann NM, Kirchner J, Umutlu L, Fendler WP, Seifert R, Herrmann K, Bittner AK, Hoffmann O, Mohrmann S, Antke C, Schimm\u00f6ller L, Ingenwerth M, Breuckmann K, Stang A, Buchbender C, Antoch G, Sawicki LM (2021) Prospective comparison of the diagnostic accuracy of 18F-FDG PET\/MRI, MRI, CT, and bone scintigraphy for the detection of bone metastases in the initial staging of primary breast cancer patients. Eur Radiol 31(11):8714\u20138724","journal-title":"Eur Radiol"},{"key":"7169_CR23","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1007\/s00761-017-0248-0","volume":"23","author":"Behandlung des fr\u00fchen Mammakarzinoms","year":"2017","unstructured":"Behandlung des fr\u00fchen Mammakarzinoms (2017) Schneeweiss, A., Huober, J., Jackisch, C. et al. 15. Internationale St.-Gallen-Konsensus-Konferenz. Onkologe 23:666\u2013677","journal-title":"Onkologe"},{"key":"7169_CR24","doi-asserted-by":"publisher","unstructured":"Untch M, Huober J, Jackisch C, Schneeweiss A, Brucker SY, Dall P, Denkert C, Fasching PA, Fehm T, Gerber B, Janni W, K\u00fchn T, L\u00fcftner D, M\u00f6bus V, M\u00fcller V, Rody A, Sinn P, Thill M, Thomssen C, Harbeck N, Liedtke C. Initial Treatment of Patients with Primary Breast Cancer: Evidence, Controversies, Consensus: Spectrum of Opinion of German Specialists at the 15th International St. Gallen Breast Cancer Conference (Vienna 2017). Geburtshilfe Frauenheilkd. 2017 Jun;77(6):633\u2013644. doi: https:\/\/doi.org\/10.1055\/s-0043-111601","DOI":"10.1055\/s-0043-111601"},{"key":"7169_CR25","doi-asserted-by":"publisher","unstructured":"Cardoso F, Kyriakides S, Ohno S, Penault-Llorca F, Poortmans P, Rubio IT, Zackrisson S, Senkus E; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up\u2020. Ann Oncol. 2019 Aug 1;30(8):1194\u20131220. https:\/\/doi.org\/10.1093\/annonc\/mdz173. Erratum in: Ann Oncol. 2019 Oct 1;30(10):1674. Erratum in: Ann Oncol. 2021 Feb;32(2):284","DOI":"10.1093\/annonc\/mdz173"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-023-07169-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-023-07169-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-023-07169-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,24]],"date-time":"2024-02-24T10:05:39Z","timestamp":1708769139000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-023-07169-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,7]]},"references-count":25,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,4]]}},"alternative-id":["7169"],"URL":"https:\/\/doi.org\/10.1007\/s00404-023-07169-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3101141\/v1","asserted-by":"object"}]},"ISSN":["1432-0711"],"issn-type":[{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,7]]},"assertion":[{"value":"29 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This was an observational study. This study is in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}